Clinical Trial Update: Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. [Phase 3]

View source ↗

Summary

A Phase 3 trial in children aged 1 to 11 with erosive esophagitis shows endoscopic evidence that maintenance therapy with oral esomeprazole (NEXIUM) preserves h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Erosive Esophagitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING